Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations

Journal of Lipid Research

H.Bryan Brewer, Jr.¹  Edward B. Neufeld¹  Catherine L. Knapper¹  Jamila Fruchart-Najib¹  Silvia Santamarina-Fojo²  John Stonik²  Lita Freeman²  Marcelo J.A. Amar²  Federica Basso³  Nicholas Duverger³  Terese Tansey³  Alan Remaley³ 

[1] Aventis Pharma, Vitry sur Seine, France;Institut Pasteur, Department d'Atherosclerose, Lille, France;Molecular Disease Branch, NHLBI, National Institutes of Health, Bethesda, MD 20862;

关键词: reverse cholesterol transport;    lipoprotein;    cholesterol;    Tangier disease;   

DOI  :  

来源: DOAJ

【 摘 要 】

The current model for reverse cholesterol transport proposes that HDL transports excess cholesterol derived primarily from peripheral cells to the liver for removal. However, recent studies in ABCA1 transgenic mice suggest that the liver itself may be a major source of HDL cholesterol (HDL-C). To directly investigate the hepatic contribution to plasma HDL-C levels, we generated an adenovirus (rABCA1-GFP-AdV) that targets expression of mouse ABCA1-GFP in vivo to the liver. Compared with mice injected with control AdV, infusion of rABCA1-GFP-AdV into C57Bl/6 mice resulted in increased expression of mouse ABCA1 mRNA and protein in the liver. ApoA-I-dependent cholesterol efflux was increased 2.6-fold in primary hepatocytes isolated 1 day after rABCA1-GFP-AdV infusion. Hepatic ABCA1 expression in C57Bl/6 mice (n = 15) raised baseline levels of TC, PL, FC, HDL-C, apoE, and apoA-I by 150–300% (P < 0.05 all). ABCA1 expression led to significant compensatory changes in expression of genes that increase hepatic cholesterol, including HMG-CoA reductase (3.5-fold), LDLr (2.1-fold), and LRP (5-fold) in the liver.These combined results demonstrate that ABCA1 plays a key role in hepatic cholesterol efflux, inducing pathways that modulate cholesterol homeostasis in the liver, and establish the liver as a major source of plasma HDL-C.

【 授权许可】

Unknown